Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Almotriptan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D known ✓ | P28221 | 2/20 | 0.39 |
| ▸ | HTR1B known ✓ | P28222 | 2/20 | 0.39 |
| ▸ | HTR1F known ✓ | P30939 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 3/20 | 0.61 |
| ▸ | HTR2B | P41595 | 3/20 | 0.61 |
| ▸ | HTR2C | P28335 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.61 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.61 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.61 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.61 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.61 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.61 |
| ▸ | HRH1 | P35367 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sumatriptan SCHEMBL17596129 | 0.90 | HTR2C (0.63) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Eletriptan SCHEMBL17596370 | 0.83 | HTR1B (0.58) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Diphenhydramine SCHEMBL5128 | 0.78 | LMNA (1.00) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Diphenhydramine SCHEMBL1896940 | 0.78 | LMNA (1.00) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Diphenhydramine SCHEMBL5670807 | 0.78 | LMNA (1.00) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Naratriptan SCHEMBL17595421 | 0.78 | ALDH1A1 (0.57) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Diphenhydramine SCHEMBL10385770 | 0.77 | LMNA (0.98) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Diphenhydramine SCHEMBL7933565 | 0.77 | LMNA (0.98) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Diphenhydramine SCHEMBL28213087 | 0.76 | LMNA (0.94) | HTR2AHTR2BHTR2CLMNAADRA2B | |
| Diphenhydramine SCHEMBL5085363 | 0.74 | ALDH1A1 (0.91) | HTR2AHTR2BHTR2CLMNAADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3191093-A1 | PHARMACEUTICAL COMPOSITIONS | Charleston Laboratories, Inc. (US) | 2017-07-19 | — | — | EP | disclosed |
| WO-2016040358-A1 | PHARMACEUTICAL COMPOSITIONS | CHARLESTON LABORATORIES, INC. (US) | 2016-03-17 | — | — | WO | disclosed |